Search - tctmd.com

Presenter: Koen Teeuwen, Ben Van den Branden, Jacques Koolen, Jose Henriques, Jan Tijssen, Hans Kelder, Ren? Van der Schaaf, Paul Vermeersch, Benno Rensing, Maarten j. Suttorp

January 31, 2013

Presentation TCT 2013

THREE YEAR FOLLOW UP OF A RANDOMIZED COMPARISON OF NOBORI, BIOLIMUS A9 ELUTING STENT(BES) WITH CYPHER, SIROLIMUS ELUTING STENT(SES) FOR CORONARY REVASCULARIZATION IN JAPANESE...

Presenter: Takeshi Kimura, Toshiya Muramatsu, Masashi Iwabuchi, Shigeru Saito, Yasuhiko Hayashi, Yuji Ikari, Kenshi Fujii, Shinsuke Nanto, Naoto Inoue, Atsuo Namiki, Haruo Hirayama, Osamu Doi, Mitsuo Kashida, Junji Yajima, Kazuaki Mitsudo

January 31, 2013

$The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after...$

Presentation TCT 2013

The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after...

Presenter: Tahei Ichinohe, Kazushige Kadota, Haruki Eguchi, Seiji Habara, Hiroyuki Tanaka, Takeshi Tada, Yasushi Fuku, Naoki Oka, Hiroyuki Yamamoto, Satoki Fujii, Tsuyoshi Goto, Kazuaki Mitsudo

January 31, 2013

Presentation TCT 2013

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Presenter: Aris Moschovitis, Giulio Stefanini, Michael Magro, Lorenz R?ber, Bindu Kalesan, Masanori Taniwaki, Joost Daemen, Peter Wenaweser, Ron Van Domburg, Bernhard Meier, Peter Juni, Patrick Serruys, Stephan Windecker

January 31, 2013

Presentation TCT 2013

Seven-year Clinical Outcomes of Sirolimus-Eluting Stent Versus Bare-Metal Stent; A Matched Analysis From A Real World, Single Center Registry

Presenter: Jin-Sung Lee, Yoon-Jung Choi, Ung Kim, Jong-Seon Park, Jang-Won Son, Sang-Hee Lee, Dong-Gu Shin, Young-Jo Kim

January 31, 2013

Presentation TCT 2013

NOYA I: A Prospective Randomized Trial of the Biodegradable Polymer NOYA Sirolimus-Eluting Stent Compared with the Durable Polymer FIREBIRD 2 Sirolimus-Eluting Stent in Patients...

Presenter: Bo Xu, Kefei Dou, Yuejin Yang, Shuzheng Lu, Lefeng Wang, Haichang Wang, Zhanquan Li, Lei Wang, YunDai Chen, Yong Huo, Ajay Kirtane, Run-Lin Gao

January 31, 2013

Presentation TCT 2013

LONG TERM OUTCOME OF PATIENTS WITH BIFURCATED LESIONS RANDOMIZED TO SIROLIMUS OR EVEROLIMUS ELUTING STENT: THE SEA-CORP BC STUDY

Presenter: Francesco Burzotta, Pan Manuel, Trani Carlo, Medina Alfonso, SU?REZ DE LEZO Jos?, Niccoli Giampaolo, Romero Miguel, Porto Italo, Mazuelos Francisco, Leone Antonio Maria, Martin Pedro, Valentina Coluccia, SU?REZ DE LEZO Javier, OJEDA Soledad, Crea Filippo

January 31, 2013

Advertisement

Cardiovascular Summit TCTAP 2013 Symposium to Feature OrbusNeich’s COMBO Dual Therapy Stent™

Mortality Varies by Revascularization Method in Dialysis Patients

Los SLF de Rescate son Efectivos en Pacientes con ICE y Lesiones por Debajo de la Rodilla

La Mortalidad Varía según el Método de Revacularización en Pacientes a Diálisis

Bailout DES Effective in CLI Patients with Below-the-Knee Lesions

REMEDEE Published: ‘Dual Therapy’ Stent Passes Early Efficacy, Safety Tests

REMEDEE Publicado: El Stente de ‘Tratamiento Doble’ Aprueba, sin Problemas, los Tests de Seguridad y Eficacia

The REMEDEE Trial: A Randomized Comparison of a Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stent with a PES

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

BIOSOLVE-1 Confirma la Mejora en los Stents Bioabsorbibles liberadores de Paclitaxel

Los SLE No son Inferiores a los SLS en el Tratamiento de las Oclusiones Coronarias Totales

EES Noninferior to SES for Treating Total Coronary Occlusions

Randomized Comparison of Sirolimus-eluting (SES) and Everolimus-eluting (EES) Coronary Stents in the Treatment of Total Coronary Occlusions

Two-year Clinical Outcomes Of Primary Stenting Of Totally Occluded Native Coronary Arteries III (PRISON III): A Randomized Comparison Of Sirolimus-Eluting Stent Implantation Wit...

THREE YEAR FOLLOW UP OF A RANDOMIZED COMPARISON OF NOBORI, BIOLIMUS A9 ELUTING STENT(BES) WITH CYPHER, SIROLIMUS ELUTING STENT(SES) FOR CORONARY REVASCULARIZATION IN JAPANESE...

The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after...

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Seven-year Clinical Outcomes of Sirolimus-Eluting Stent Versus Bare-Metal Stent; A Matched Analysis From A Real World, Single Center Registry

NOYA I: A Prospective Randomized Trial of the Biodegradable Polymer NOYA Sirolimus-Eluting Stent Compared with the Durable Polymer FIREBIRD 2 Sirolimus-Eluting Stent in Patients...

LONG TERM OUTCOME OF PATIENTS WITH BIFURCATED LESIONS RANDOMIZED TO SIROLIMUS OR EVEROLIMUS ELUTING STENT: THE SEA-CORP BC STUDY

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content